NCT02231905View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2004

Conditions
Parkinson Disease
Interventions
DRUG

BI-Sifrol®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY